• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肾嗜酸性空泡状肿瘤:临床病理及分子特征]

[Eosinophilic vacuolated tumor of the kidney: clinicopathological and molecular characteristics].

作者信息

Zhang H Z, Xia Q Y, Yin X G, Wang S Y

机构信息

Department of Pathology, Ningbo Diagnostic Pathology Center, Ningbo 315000, China.

Department of Pathology, Nanjing Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, China.

出版信息

Zhonghua Bing Li Xue Za Zhi. 2022 May 8;51(5):437-443. doi: 10.3760/cma.j.cn112151-20210908-00660.

DOI:10.3760/cma.j.cn112151-20210908-00660
PMID:35511640
Abstract

To study the clinicopathological features, immunophenotype, molecular changes, differential diagnosis and prognosis of eosinophilic vacuolated tumor (EVT) of the kidney. Four cases were collected retrospectively from 2014 to 2020 at Ningbo Diagnostic Pathology Center. The clinicopathologic features and immunophenotypic profile were studied by light microscopy and immunohistochemistry. Targeted next-generation sequencing (NGS) panel was used to detect cancer-associated mutation. Follow-up and literature review were also performed. Among the 4 patients studied,2 were males and 2 were females. The age of the patients ranged from 44 to 63 years (the mean age: 51 years).Tumor size ranged from 1.5 to 4.2 cm (mean: 2.3 cm). Microscopically, tumors were well-circumscribed, unencapsulated. Thick-walled vessels and entrapped renal tubules were found within or at the periphery of the tumors. The tumors were predominantly composed of nest pattern, and focal tubular pattern. The tumor cells exhibited abundant, eosinophilic, granular cytoplasm and conspicuous, large nucleoli. Prominent intracytoplasmic vacuoles were seen. These cytoplasmic vacuoles varied in size and frequently coalesced into a large space. Loose fibromatous or hyaline stroma was focally noted. Immunohistochemically, the tumor cells in all cases exhibited a CD117+/CK7-phenotype. All cases were positive for CD10 and p504s. MTOR, S6 and cathepsin K were positive in 4 cases. TFE3, CA9, Melan A and HMB45 were negative in all cases. SDHB retained expression. NGS demonstrated MTOR mutations in all cases, and TSC2 mutation in 2 cases. EVT is a rarely oncocytic renal tumor with unique morphology, immunohistochemical phenotype, molecular profile and an indolent behavior. Recognition of the characteristics of this novel but rare entity will allow for better classification of renal tumors.

摘要

研究肾嗜酸性空泡状肿瘤(EVT)的临床病理特征、免疫表型、分子改变、鉴别诊断及预后。回顾性收集2014年至2020年宁波诊断病理中心的4例病例。通过光学显微镜和免疫组织化学研究临床病理特征及免疫表型。采用靶向二代测序(NGS)检测癌症相关突变。同时进行随访及文献复习。在研究的4例患者中,男性2例,女性2例。患者年龄44至63岁(平均年龄:51岁)。肿瘤大小1.5至4.2厘米(平均:2.3厘米)。显微镜下,肿瘤边界清楚,无包膜。肿瘤内部或周边可见厚壁血管及被包绕的肾小管。肿瘤主要由巢状结构组成,局灶可见管状结构。肿瘤细胞胞质丰富、嗜酸性、呈颗粒状,核仁明显、较大。可见显著的胞质内空泡。这些胞质内空泡大小不一,常融合成一个大的腔隙。局灶可见疏松的纤维瘤样或玻璃样间质。免疫组织化学显示,所有病例肿瘤细胞均表现为CD117阳性/CK7阴性表型。所有病例CD10和p504s均为阳性。4例MTOR、S6和组织蛋白酶K阳性。所有病例TFE3、CA9、Melan A和HMB45均为阴性。SDHB保留表达。NGS显示所有病例均有MTOR突变,2例有TSC2突变。EVT是一种罕见的嗜酸性肾肿瘤,具有独特的形态、免疫组织化学表型、分子特征及惰性生物学行为。认识这种新的罕见实体的特征将有助于更好地对肾肿瘤进行分类。

相似文献

1
[Eosinophilic vacuolated tumor of the kidney: clinicopathological and molecular characteristics].[肾嗜酸性空泡状肿瘤:临床病理及分子特征]
Zhonghua Bing Li Xue Za Zhi. 2022 May 8;51(5):437-443. doi: 10.3760/cma.j.cn112151-20210908-00660.
2
Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases.肾脏嗜酸性空泡肿瘤(EVT)显示散发性 TSC/MTOR 突变:19 例的下一代测序多机构研究。
Mod Pathol. 2022 Mar;35(3):344-351. doi: 10.1038/s41379-021-00923-6. Epub 2021 Sep 14.
3
Somatic Mutations of TSC2 or MTOR Characterize a Morphologically Distinct Subset of Sporadic Renal Cell Carcinoma With Eosinophilic and Vacuolated Cytoplasm.TSC2 或 MTOR 的体细胞突变特征是具有嗜酸性和空泡状细胞质的散发性肾细胞癌的形态学上明显不同的亚群。
Am J Surg Pathol. 2019 Jan;43(1):121-131. doi: 10.1097/PAS.0000000000001170.
4
Low-grade oncocytic tumor of kidney harboring TSC/MTOR mutation: clinicopathologic, immunohistochemical and molecular characteristics support a distinct entity.携带TSC/MTOR突变的肾脏低级别嗜酸性细胞瘤:临床病理、免疫组化及分子特征支持其为一种独特的实体瘤。
Virchows Arch. 2022 May;480(5):999-1008. doi: 10.1007/s00428-022-03283-x. Epub 2022 Jan 31.
5
[Renal eosinophilic vacuolated tumor: a clinicopathological analysis of seven cases].[肾嗜酸性空泡状肿瘤:7例临床病理分析]
Zhonghua Bing Li Xue Za Zhi. 2024 Sep 8;53(9):910-915. doi: 10.3760/cma.j.cn112151-20240201-00074.
6
[Clinicopathological features of low-grade oncocytic renal tumor (CD117-negative, cytokeratin 7-positive): report of seven cases].[低级别嗜酸性肾肿瘤(CD117阴性,细胞角蛋白7阳性)的临床病理特征:7例报告]
Zhonghua Bing Li Xue Za Zhi. 2022 Aug 8;51(8):719-725. doi: 10.3760/cma.j.cn112151-20220410-00263.
7
[Eosinophilic solid and cystic renal cell carcinoma: clinicopathological analysis and molecular characterization].[嗜酸性实性和囊性肾细胞癌:临床病理分析及分子特征]
Zhonghua Bing Li Xue Za Zhi. 2019 Nov 8;48(11):840-845. doi: 10.3760/cma.j.issn.0529-5807.2019.11.002.
8
Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations.肾脏低级别嗜酸细胞瘤(LOT)的特征是 GATA3 阳性、FOXI1 阴性和 mTOR 通路突变。
Pathol Oncol Res. 2023 Feb 1;29:1610852. doi: 10.3389/pore.2023.1610852. eCollection 2023.
9
"Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.“伴平滑肌样基质的肾细胞癌”存在 TSC1、TSC2、MTOR 和/或 ELOC(TCEB1)体细胞突变:18 例散发性肿瘤的临床病理和分子特征支持其为一种独特实体。
Am J Surg Pathol. 2020 May;44(5):571-581. doi: 10.1097/PAS.0000000000001422.
10
[Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].[富马酸水合酶缺陷型肾细胞癌的临床病理特征]
Zhonghua Bing Li Xue Za Zhi. 2019 Feb 8;48(2):120-126. doi: 10.3760/cma.j.issn.0529-5807.2019.02.009.